Deciphering the Clinical Benefit of Pola-R-CHP versus R-CHOP in Different Genetic Subtypes Beyond Cell of Origin (COO) in the POLARIX Study

Autor: Morschhauser, Franck, Leung, Wilfred, Raghavan, Vibha, Lenz, Georg, Jardin, Fabrice, Herrera, Alex F., Sehn, Laurie H., Sharman, Jeff P., Flowers, Christopher R., Friedberg, Jonathan W., Trněný, Marek, Tilly, Hervé, Herbaux, Charles, Tracy, Samuel, Bolen, Christopher R., Harris, Will, Hirata, Jamie H., Lee, Calvin, Jiang, Yanwen, Lee Batlevi, Connie, Salles, Gilles
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S212-S212
Databáze: ScienceDirect
Externí odkaz: